News, Seminars &
Publications

Episode 48: The importance of antioxidants & iron chelators for comprehensive photoprotection
This episode of Skincare Confidential is likely to change the way clinicians' approach photoprotection. Work by Dr. Pourzand has demonstrated that ferulic acid is a bifunctional antioxidant and iron chelator that is valuable for skin photoprotection.
Read more
New tumour spatial mapping tool will help clinicians diagnose cancer and personalise treatment
FuncOmap directly maps the functional states of oncoproteins in patients’ tumour sections, so that clinicians can predict which treatments will work best.
Read more
Dr Millicent Stone has been awarded a Royal Society Entrepreneur in Residence Fellowship to work with the Centre of Therapeutic Innovation.
Dr Stone is one of the leading rheumatologists in the UK, who also has an impressive track record both of impactful academic research and of entrepreneurial activity.
Read more
Bath scientists develop 3D-printed artificial knee
Scientists have developed a 3D-printed implant to help patients suffering osteoarthritis in their knee.
Read more
Ligeti Quartet
IMPRISONED ABSENCE
Read more
New study brings personalised immunotherapy prescriptions a step closer
Research validates an imaging platform co-developed at CTI-Bath which predicts if a cancer patient would respond well to immunotherapy.
Read more
CTI publication outputs
CTI publications span a wide range of research areas. The figure below uses Scopus/SciVal’s broad subject categories to show the areas current CTI staff have published in since 2014.
Read more
Machine learning outperforms clinical experts in classifying hip fractures
Neural networks could improve patient outcomes and reduce care costs
Read more
Translating Spatio-Temporal Imaging Data Into Clinical Data Using Machine Learning
Tumour heterogeneity at the protein level has been associated with poor prognosis in several human carcinomas. Current approaches for assessing protein function rely on intensity-based methods, which are limited by their subjectivity and specificity.
Read more
A practical model of the diffusion of oil‐based fluid into polyethylene
It is possible to modify the properties of semicrystalline polymers using diffusion to introduce additional functionality.
Read more
New tool identifies which cancer patients are most likely to benefit from immunotherapy
A new diagnostic tool that can predict whether a cancer patient would respond to immunotherapy treatment has been developed by scientists at the University of Bath.
Read more
High PD-1/PD-L1 checkpoint interaction infers tumor selection and therapeutic sensitivity to anti-PD-1/PD-L1 treatment
Many cancers are termed immunoevasive due to expression of immunomodulatory ligands. Programmed death ligand-1 (PD-L1) and cluster of differentiation 80/86 (CD80/86) interact with their receptors, programmed death receptor-1 (PD-1) and cytotoxic T-lymphocyte associated protein-4 (CTLA-4) respectively, on tumor-infiltrating leukocytes eliciting immunosuppression.
Read more

Seminars

Professor Erick Dufourc, CNRS & University of Bordeaux, France

Joint CTI, Life Sciences and Institute for Sustainability Seminar

MRI and NMR of myelin: towards non-invasive ways to detect neuronal diseases?

Friday 24 March 2023 at 13:15 (UK-time)

See Details

Professor Keefe Manning, Pennsylvania State University, USA

Joint Mechanical Engineering and CTI Seminar

In Silico Predictions of Clotting and Embolization and the Challenge of Computational Simulations for Use in Regulatory Context

Tuesday 1 November 2022 at 13:15 (UK-time)

See Details

Professor Sussan Nourshargh - Queen Mary University of London, United Kingdom

Neutrophil breaching of venular walls: Novel concepts and pathophysiological regulation

Thursday 7 July 2022 at 12:15pm (UK-time)

See Details

Professor Luca Gerardo-Giorda- Johannes Kepler University Linz, Austria

Advanced computational modelling in the design of new cardiac radiofrequency ablation strategies

Thursday 28 April 2022 at 12:15pm (UK-time)

See Details

Professor Jennifer Dionne, Stanford, California, United States

Emerging nanophotonic platforms for infectious disease diagnostics: Re-imagining the conventional microbiology toolkit

Thursday 24 March 2022, 16:15

See Details

Professor Felix M. Goni from the University of the Basque Country, Bilbao, Spain

From Adelard to Therapeutic Innovation, via David Parkin

See Details

Professor George Kolios - Democritus University of Thrace, Alexandroupolis, Greece

Stromal cells biology in intestinal fibrosis; the role of myofibroblast

Thursday 16 December 2021, 12:15

See Details

Professor Vytas Bankaitis – Texas A&M University, United States

Neural stem cell interkinetic nuclear migration is controlled by a phosphatidylinositol transfer protein/non-canonical planar cell polarity signaling axis

Tuesday 23 November 2021, 16:15

See Details

Dr Raj Sengupta – Royal United Hospitals, Bath, United Kingdom

Future of Rheumatology care - understanding the role of precision medicine

Thursday 14 October 2021, 12:15

See Details

Dr Lucy Collinson - Francis Crick Institute, London, United Kingdom

Imaging biomedical samples across scales using light, X-rays and electrons

Thursday 29 April 2021, 16:15

See Details

Professor Luke O’Neill - Trinity College, Dublin, Ireland

Adventures in Inflammation Research

Thursday 18 March 2021, 16:15

See Details

Professor Alex Toker - Harvard University, Cambridge, Massachusetts, United States

Discovery, Mechanisms and Therapeutic Targeting of the PI 3-Kinase and AKT Signaling

Thursday 11 March 2021, 16:15

See Details

Professor Stefanie Jeffrey - Stanford University, Stanford, United States

Liquid biopsy for cancer - an update on a rapidly changing field.

Thursday 4 February 2021, 16:00

See Details

Professor Paul Skipp - University of Southampton: Centre for Proteomic Research, Southampton, United Kingdom

Precision Medicine: The Shape of Asthma

Thursday 3 December 2020, 12:15

See Details

Professor Guillaume Canaud - Necker Hospital, Paris, France

Targeted therapy in patients with PIK3CA-related overgrowth syndrome

Wednesday 25 November 2020, 13:15

See Details

Join our mailing list

Join our mailing list in order to receive the CTI newsletter and to be invited to our seminars

Subscribe